Viibryd (vilazodone) has a half-life of approximately 25 hours, meaning it takes roughly 5 to 7 days for the drug to fully clear your system after your last dose. That said, the timeline can shift depending on your liver function, other medications you take, and how long you’ve been on Viibryd.
How the 25-Hour Half-Life Works
A drug’s half-life is the time it takes for the amount in your bloodstream to drop by half. With Viibryd’s 25-hour half-life, here’s roughly what happens after your final dose:
- 25 hours: 50% of the drug remains
- 50 hours (about 2 days): 25% remains
- 75 hours (about 3 days): 12.5% remains
- 5 to 7 days: less than 3% remains, and the drug is considered effectively cleared
Pharmacologists typically use five to seven half-lives as the benchmark for near-complete elimination. For Viibryd, that works out to about 125 to 175 hours, or roughly 5 to 7 days.
What Affects How Quickly You Clear It
Viibryd is broken down primarily in the liver, with one enzyme family (CYP3A4) doing most of the work and two others playing smaller roles. This means anything that affects liver enzyme activity can speed up or slow down elimination.
If you’re taking a strong CYP3A4 inhibitor (certain antifungal or HIV medications, grapefruit juice in large amounts), your body processes Viibryd roughly half as fast. Blood levels of the drug can essentially double, and it will linger longer after your last dose. On the flip side, CYP3A4 inducers (some seizure medications, for example) can accelerate clearance, potentially pushing the drug out of your system faster than the standard timeline.
Liver health matters too. Since the liver is the primary route of elimination, reduced liver function can extend the time Viibryd stays in your body, though the FDA prescribing information doesn’t specify an adjusted half-life for liver impairment.
Peak Levels and Absorption
After taking a dose, Viibryd reaches its highest concentration in your blood at about 4 to 5 hours. Its bioavailability (the fraction that actually makes it into your bloodstream) is 72% when taken with food. This is why Viibryd is always supposed to be taken with a meal: without food, absorption drops significantly, which can reduce the drug’s effectiveness.
The 14-Day Washout for MAOIs
If you’re switching from Viibryd to an MAOI antidepressant, you need to wait at least 14 days after your last Viibryd dose before starting the new medication. This is twice as long as the drug’s physical elimination window, and the extra buffer exists because combining these two drug classes, even with trace amounts overlapping, can trigger a dangerous reaction called serotonin syndrome. The same 14-day rule applies in reverse: you must stop an MAOI at least 14 days before starting Viibryd.
Withdrawal Symptoms After Stopping
Even after Viibryd has technically cleared your bloodstream, your brain may still be adjusting to its absence. Antidepressant discontinuation syndrome can produce symptoms like dizziness, nausea, irritability, “brain zaps” (brief electrical-shock sensations), and sleep disturbances. A large pharmacovigilance analysis of over 31,000 reports found that the median duration of antidepressant withdrawal symptoms was about 1 day, though 74.4% of reported cases were classified as serious. In those serious cases, symptoms lasted significantly longer, averaging around 25 days.
The risk and severity of withdrawal generally increase the longer you’ve been taking the medication and the higher your dose. This is why prescribers typically recommend a gradual taper rather than stopping abruptly. A slow dose reduction gives your brain time to recalibrate its serotonin signaling, which reduces the chance of rebound symptoms.
Drug Testing Considerations
Viibryd is not a controlled substance and is not included on standard drug screening panels. It’s an antidepressant that works on serotonin pathways, not a benzodiazepine, amphetamine, or opioid. In rare cases, certain antidepressants can cause false positives on immunoassay-based urine screens, but a confirmatory test would quickly rule out any cross-reactivity. If you’re concerned about a specific test, letting the testing facility know what medications you take beforehand is the simplest way to avoid confusion.